LOGIN
ID
PW
MemberShip
2025-11-17 15:17
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
Input Time : 2019-11-15
[Download file]
go back
OPINION
[Reporter¡¯s View] K-obesity drugs need to innovate
Reporter's view |
Choi, Da-eun
[Reporter¡¯s View] ¡®Selection & Focus¡¯ to foster K-Bios
Reporter's view |
Hwang, byoung woo
[Desk View] Unsettling relief from pharma tariff agreement
Desk's view |
Chon, Seung-Hyun
INTERVIEW
ADCs rise to become SOC in key solid tumors
Enhertu overtakes Kadcyla and becomes the standard of care¡¦ pushes into first-line
"GI Innovation challenges melanoma"
"...overcoming resistance to PD-1 antibodies" says Myoung Ho Jang, CEO of GI Innovation
"New landscape in DLBCL trt¡¦Columvi¡¤Polivy's bigger role"
Professor Gareth Gregory of Monash University in Australia
"Gilead-Kite will lead the trt landscape for DLBCL in KOR"
Diego Santoro, Head of the International Region for Kite Pharma
Dong-A ST launches Sterlara biosimilar Imuldosa in the US
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
"Expanded access to Pergoveris¡¦for older infertile women"
2
AZ runs Lung Health Check Bus¡¦screens Changwon residents
3
Pricing nego for Erleada underway¡¦last hurdle to reimb
4
Generic company challenges flu drug Xofluza¡¯s patent
5
Pharmaceutical post-market management system to be enhanced
6
Ultomiris gains reimbursement approval for 'NMOSD¡¤gMG'
7
What's the outcome of the 2nd reimb attempt for 'Uplizna'?
8
First batch of drugs gain reimb through AEN pilot project
9
KMA protests in front of the NA opposing INN prescribing
10
Generic companies win 1st trial on unlisted Jardiance patent